The Neurontin legacy--marketing through misinformation and manipulation

N Engl J Med. 2009 Jan 8;360(2):103-6. doi: 10.1056/NEJMp0808659.
No abstract available

Publication types

  • Historical Article

MeSH terms

  • Amines / history*
  • Cyclohexanecarboxylic Acids / history*
  • Drug Industry / ethics
  • Drug Industry / history*
  • Drug Labeling / history
  • Drug Labeling / legislation & jurisprudence
  • Gabapentin
  • History, 20th Century
  • History, 21st Century
  • Humans
  • Marketing / ethics
  • Marketing / history*
  • Marketing / legislation & jurisprudence
  • United States
  • United States Food and Drug Administration
  • gamma-Aminobutyric Acid / history*

Substances

  • Amines
  • Cyclohexanecarboxylic Acids
  • gamma-Aminobutyric Acid
  • Gabapentin